We are moving to Bluesky! Find us at bonellilab@bsky.social Accordingly, we will gradually stop posting here on X. Join us on Bluesky and let's stay connected!.

🎥 Delve into future personalized medical approaches in rheumatology with @DanielAletaha and Michael, featured in a recent @ORF interview. 📺 Catch the full interview here (in German): (jump to 33:16 for our segment). #Rheumatology #ScienceCommunication.

🌟Excited to share our recent publication in Cell Reports: "HDAC1 fine-tunes Th17 polarization in vivo to restrain tissue damage in fungal infections." Kudos to all co-authors for their contributions!.📖 Read more here: #Immunology #Research.

🎉 Exciting news! The Ludwig Boltzmann Institute for Network Medicine (LBI NetMed) is live under Jörg Menche's leadership! 🌟 Tackling complex challenges at the intersection of medicine & network science. 🚀 Congrats to the team! More: #NetworkMedicine

🚨 Postdoc Opportunity in Autoimmunity 🚨.Join our team @MedUni_Wien to study triggers of IR-NCDs like RA & SLE as part of the Horizon-Europe DarkMatter Project. 📅 Apply by Jan 15, 2025.🔗 Details in the attachment and at

🖌️Our new website, built with @TeamSciStories, is live! 🌐 Explore:.✨ Our vision & cutting-edge rheumatic disease research.✨ Ongoing projects, job offers, team, & publications.✨ News & collaborations, all with custom science art.Check it out & share! ♻.

Thrilled to be at the @SQUEEZE_project General Assembly in Bucharest🤝and to reconnect with Costantino Pitzalis and @FeliceRivellese from @QMUL as we advance #PrecisionMedicine for #RheumatoidArthritis with the BioTest trial. 🧬#Biomarkers #SynovialBiopsy

🚀 Verstärken Sie unser Team! Wir suchen eine*n Medizinischen Technischen Assistentin (MTA) für unser Rheumatologie-Labor an der Medizinischen Universität Wien!.➡️ Jetzt bewerben! Mehr Infos: #Jobs #Rheumatologie #MTABewerbung #Wien

🤝 Our talented PhD student Mirjam Dellinger successfully started a six-months collaboration with the team of Costantino Pitzalis at @QMUL within the frame of @SQUEEZE_project ! Thanks to SQUEEZE and the Marietta Blau-Stipendium for the financial support of this collaboration.🙏

We are thrilled to welcome Laura Hermann to our team as of this week! Laura will work as a PhD student within the @FWF_at Program SHIELD to decipher the mechanisms that drive the development of pathogenic T cells and their role in #inflammatory #arthritis.

🎙️It was a pleasure and an honor to co-chair the session on synovial inflammation hosted yesterday by @eular_org at the #ECI2024 in Dublin together with @FeliceRivellese. What an inspiring congress for the Rheumatology Research community!

📣Our lab is recruiting again, help us spread the word! 📣 We are offering a (paid) Master student position to study with us the role of epigenetic modifications in Arthritis. Check our job ad on the link or the attached pictures below 👇.

☀️Our team is embracing the summer in Vienna, and proudly accomplished a “Rätselrallye” during our annual summer retreat last week! Well-deserved dinner & drinks followed to reward our team. Summery greetings from Vienna!

This work was a group effort together with @inflammationHL, Henriette Kirchner, @GerhardKronke and Gabriela Riemekasten.

Our work provides a comprehensive view on the topic, with a focus on tissue-occupying cells in #arthritis and systemic sclerosis (Ssc) and on the most promising treatment options targeting the, so to say, “maladaptive” inflammatory tissue priming in these diseases.

What is inflammatory tissue priming, and why is it so important to understand it to find new treatments against rheumatic diseases ? Check out our most recent review to find out:

📣Our lab is recruiting, help us spread the word! 📣 We are offering a (paid) Master student position in computational biology to study with us the role of epigenetic modifications in Arthritis. Check our job ad on the link below👇 .

Back from a very successful meeting with our collaborators from @id_dm_ncd in Kiel 🇩🇪 ! Our team spent two days of fruitful discussions to optimize our research plans towards finding new factors responsible for immune-related non-communicable diseases.

Our very own Daniel Mrak presented his latest data on the management of Polymalgia rheumatic patients with Interleukin-6 inhibitors in the poster sessions of #EULAR2024 and obtained very valuable feedback from participants! Well done Daniel! 👏

🎙️I had the honor and privilege to co-chair the #EULAR24 session on auto-antigens in #RheumatoidArthritis with the great Andrew Cope ( last week. A session full of inspiring talks that surely forecast breakthroughs in molecular & cellular #autoimmunity!